Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set

•Seizures occurred in 4% of recreational drug presentations to emergency departments.•Fentanyl, synthetic cannabinoids, and MDMA associated with increased seizures.•Seizures after recreational drug use associated with worse clinical outcomes. Seizures are a recognized and potentially serious complic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotoxicology (Park Forest South) 2019-07, Vol.73, p.183-187
Hauptverfasser: Wolfe, Caitlin E., Wood, David M., Dines, Alison, Whatley, Benjamin P., Yates, Christopher, Heyerdahl, Fridtjof, Hovda, Knut Erik, Giraudon, Isabelle, Dargan, Paul I., Anseeuw, Kurt, Badaras, Robertas, Bonnici, Jeffrey, Brvar, Miran, Caganova, Blazena, Ceschi, Alessandro, Eyer, Florian, Galicia, Miguel, Geith, Stefanie, Gillebeert, Johan, Grenc, Damjan, Gorozia, Ketevan, Jaffal, Karim, Jürgens, Gesche, Kabata, Piotr Maciej, Kennedy, Iarlaith, Konstari, Jutta, Kutubidze, Soso, Laubner, Gabija, Liakoni, Evangelia, Liechti, Matthias E., Lyphout, Cathelijne, Mégarbane, Bruno, Miró, Òscar, Moughty, Adrian, Müller, Laura, O'Connor, Niall, Paasma, Raido, Perez, Juan Ortega, Perminas, Marius, Persett, Per Sverre, Põld, Kristiina, Puiguriguer, Jordi, Radenkova-Saeva, Julia, Rulisek, Jan, Schmid, Yasmin, Scholz, Irene, Sopirala, Radhika, Surkus, Jonas, Toth, Ibolya, Vallersnes, Odd Martin, Vigorita, Federico, Waldman, Wojciech, Waring, W. Stephen, Zacharov, Sergej
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 187
container_issue
container_start_page 183
container_title Neurotoxicology (Park Forest South)
container_volume 73
creator Wolfe, Caitlin E.
Wood, David M.
Dines, Alison
Whatley, Benjamin P.
Yates, Christopher
Heyerdahl, Fridtjof
Hovda, Knut Erik
Giraudon, Isabelle
Dargan, Paul I.
Anseeuw, Kurt
Badaras, Robertas
Bonnici, Jeffrey
Brvar, Miran
Caganova, Blazena
Ceschi, Alessandro
Eyer, Florian
Galicia, Miguel
Geith, Stefanie
Gillebeert, Johan
Grenc, Damjan
Gorozia, Ketevan
Jaffal, Karim
Jürgens, Gesche
Kabata, Piotr Maciej
Kennedy, Iarlaith
Konstari, Jutta
Kutubidze, Soso
Laubner, Gabija
Liakoni, Evangelia
Liechti, Matthias E.
Lyphout, Cathelijne
Mégarbane, Bruno
Miró, Òscar
Moughty, Adrian
Müller, Laura
O'Connor, Niall
Paasma, Raido
Perez, Juan Ortega
Perminas, Marius
Persett, Per Sverre
Põld, Kristiina
Puiguriguer, Jordi
Radenkova-Saeva, Julia
Rulisek, Jan
Schmid, Yasmin
Scholz, Irene
Sopirala, Radhika
Surkus, Jonas
Toth, Ibolya
Vallersnes, Odd Martin
Vigorita, Federico
Waldman, Wojciech
Waring, W. Stephen
Zacharov, Sergej
description •Seizures occurred in 4% of recreational drug presentations to emergency departments.•Fentanyl, synthetic cannabinoids, and MDMA associated with increased seizures.•Seizures after recreational drug use associated with worse clinical outcomes. Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20–5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19–3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35–0.61), clonazepam (OR 0.22, 95% CI 0.06–0.91), and cannabis (OR 0.65, 95% CI 0.50–0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.
doi_str_mv 10.1016/j.neuro.2019.04.003
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03859994v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161813X19300324</els_id><sourcerecordid>2209602717</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-56b36e106cad9c79ce1638be5140a1072622a3d635a279168e87791853b16ec73</originalsourceid><addsrcrecordid>eNp9kVtrFDEUgIModm39BYIEfKkPM-YkM7kIPiztaoVFCyoIPoRs5qzNMrtZk5lC--ub6dY--CAEDid855J8hLwCVgMD-W5T73BMseYMTM2amjHxhMxAK14ZBfCUzAoFlQbx84i8yHnDGLRKmufkSDCjGhB8Rn59w3A7JszUlUN93O774N0Q4o7GNU3oE95nrqddGn_TMeN7Oi_pTQ55QoYrpIuyR3W--EIv-zHTzg2uyjickGdr12d8-RCPyY-Pi-9nF9Xy66fPZ_Nl5ZtGDVUrV0IiMOldZ7wyHkEKvcIWGuaAKS45d6KTonVcGZAatSpRt2IFEr0Sx-Ttoe-V6-0-ha1LNza6YC_mSzvdMaFbY0xzDYU9PbD7FP-MmAe7Ddlj37sdxjFbzpmRjCuY2r75B93EMZWXT5TUUvOm0YUSB8qnmHPC9eMGwOzkyW7svSc7ebKsscVTqXr90HtcbbF7rPkrpgAfDgCWj7sOmGz2AXceu1CcDLaL4b8D7gCwkaGM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2268682448</pqid></control><display><type>article</type><title>Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wolfe, Caitlin E. ; Wood, David M. ; Dines, Alison ; Whatley, Benjamin P. ; Yates, Christopher ; Heyerdahl, Fridtjof ; Hovda, Knut Erik ; Giraudon, Isabelle ; Dargan, Paul I. ; Anseeuw, Kurt ; Badaras, Robertas ; Bonnici, Jeffrey ; Brvar, Miran ; Caganova, Blazena ; Ceschi, Alessandro ; Eyer, Florian ; Galicia, Miguel ; Geith, Stefanie ; Gillebeert, Johan ; Grenc, Damjan ; Gorozia, Ketevan ; Jaffal, Karim ; Jürgens, Gesche ; Kabata, Piotr Maciej ; Kennedy, Iarlaith ; Konstari, Jutta ; Kutubidze, Soso ; Laubner, Gabija ; Liakoni, Evangelia ; Liechti, Matthias E. ; Lyphout, Cathelijne ; Mégarbane, Bruno ; Miró, Òscar ; Moughty, Adrian ; Müller, Laura ; O'Connor, Niall ; Paasma, Raido ; Perez, Juan Ortega ; Perminas, Marius ; Persett, Per Sverre ; Põld, Kristiina ; Puiguriguer, Jordi ; Radenkova-Saeva, Julia ; Rulisek, Jan ; Schmid, Yasmin ; Scholz, Irene ; Sopirala, Radhika ; Surkus, Jonas ; Toth, Ibolya ; Vallersnes, Odd Martin ; Vigorita, Federico ; Waldman, Wojciech ; Waring, W. Stephen ; Zacharov, Sergej</creator><creatorcontrib>Wolfe, Caitlin E. ; Wood, David M. ; Dines, Alison ; Whatley, Benjamin P. ; Yates, Christopher ; Heyerdahl, Fridtjof ; Hovda, Knut Erik ; Giraudon, Isabelle ; Dargan, Paul I. ; Anseeuw, Kurt ; Badaras, Robertas ; Bonnici, Jeffrey ; Brvar, Miran ; Caganova, Blazena ; Ceschi, Alessandro ; Eyer, Florian ; Galicia, Miguel ; Geith, Stefanie ; Gillebeert, Johan ; Grenc, Damjan ; Gorozia, Ketevan ; Jaffal, Karim ; Jürgens, Gesche ; Kabata, Piotr Maciej ; Kennedy, Iarlaith ; Konstari, Jutta ; Kutubidze, Soso ; Laubner, Gabija ; Liakoni, Evangelia ; Liechti, Matthias E. ; Lyphout, Cathelijne ; Mégarbane, Bruno ; Miró, Òscar ; Moughty, Adrian ; Müller, Laura ; O'Connor, Niall ; Paasma, Raido ; Perez, Juan Ortega ; Perminas, Marius ; Persett, Per Sverre ; Põld, Kristiina ; Puiguriguer, Jordi ; Radenkova-Saeva, Julia ; Rulisek, Jan ; Schmid, Yasmin ; Scholz, Irene ; Sopirala, Radhika ; Surkus, Jonas ; Toth, Ibolya ; Vallersnes, Odd Martin ; Vigorita, Federico ; Waldman, Wojciech ; Waring, W. Stephen ; Zacharov, Sergej ; Euro-DEN Research Group</creatorcontrib><description>•Seizures occurred in 4% of recreational drug presentations to emergency departments.•Fentanyl, synthetic cannabinoids, and MDMA associated with increased seizures.•Seizures after recreational drug use associated with worse clinical outcomes. Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20–5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19–3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35–0.61), clonazepam (OR 0.22, 95% CI 0.06–0.91), and cannabis (OR 0.65, 95% CI 0.50–0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.</description><identifier>ISSN: 0161-813X</identifier><identifier>EISSN: 1872-9711</identifier><identifier>DOI: 10.1016/j.neuro.2019.04.003</identifier><identifier>PMID: 30974132</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute toxicity ; Adult ; Body Temperature - drug effects ; Cannabinoids ; Cannabinoids - adverse effects ; Cannabinoids - chemical synthesis ; Cannabis ; Cardiology and cardiovascular system ; Clonazepam ; Coma ; Complications ; Confidence intervals ; Datasets ; Demographics ; Drug abuse ; Drug use ; Drugs ; Emerging diseases ; Europe - epidemiology ; Female ; Fentanyl ; Hemodynamics - drug effects ; Heroin ; Human health and pathology ; Humans ; Illicit Drugs - adverse effects ; Illicit Drugs - chemical synthesis ; Incidence ; Infectious diseases ; Intoxication ; Intubation ; Life Sciences ; Male ; Narcotic Antagonists - adverse effects ; New psychoactive substances ; Opioid-Related Disorders - epidemiology ; Prognosis ; Psychotropic Drugs - adverse effects ; Psychotropic Drugs - chemical synthesis ; Pulmonology and respiratory tract ; Recreational drug ; Recreational use ; Respiration - drug effects ; Risk Assessment ; Risk Factors ; Seizure ; Seizures ; Seizures - chemically induced ; Seizures - diagnosis ; Seizures - epidemiology ; Seizures - physiopathology ; Substance-Related Disorders - diagnosis ; Substance-Related Disorders - epidemiology ; Substance-Related Disorders - physiopathology ; Synthetic cannabinoid ; Toxicity ; Toxicology</subject><ispartof>Neurotoxicology (Park Forest South), 2019-07, Vol.73, p.183-187</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Jul 2019</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-56b36e106cad9c79ce1638be5140a1072622a3d635a279168e87791853b16ec73</citedby><cites>FETCH-LOGICAL-c447t-56b36e106cad9c79ce1638be5140a1072622a3d635a279168e87791853b16ec73</cites><orcidid>0000-0002-2522-2764</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161813X19300324$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30974132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03859994$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolfe, Caitlin E.</creatorcontrib><creatorcontrib>Wood, David M.</creatorcontrib><creatorcontrib>Dines, Alison</creatorcontrib><creatorcontrib>Whatley, Benjamin P.</creatorcontrib><creatorcontrib>Yates, Christopher</creatorcontrib><creatorcontrib>Heyerdahl, Fridtjof</creatorcontrib><creatorcontrib>Hovda, Knut Erik</creatorcontrib><creatorcontrib>Giraudon, Isabelle</creatorcontrib><creatorcontrib>Dargan, Paul I.</creatorcontrib><creatorcontrib>Anseeuw, Kurt</creatorcontrib><creatorcontrib>Badaras, Robertas</creatorcontrib><creatorcontrib>Bonnici, Jeffrey</creatorcontrib><creatorcontrib>Brvar, Miran</creatorcontrib><creatorcontrib>Caganova, Blazena</creatorcontrib><creatorcontrib>Ceschi, Alessandro</creatorcontrib><creatorcontrib>Eyer, Florian</creatorcontrib><creatorcontrib>Galicia, Miguel</creatorcontrib><creatorcontrib>Geith, Stefanie</creatorcontrib><creatorcontrib>Gillebeert, Johan</creatorcontrib><creatorcontrib>Grenc, Damjan</creatorcontrib><creatorcontrib>Gorozia, Ketevan</creatorcontrib><creatorcontrib>Jaffal, Karim</creatorcontrib><creatorcontrib>Jürgens, Gesche</creatorcontrib><creatorcontrib>Kabata, Piotr Maciej</creatorcontrib><creatorcontrib>Kennedy, Iarlaith</creatorcontrib><creatorcontrib>Konstari, Jutta</creatorcontrib><creatorcontrib>Kutubidze, Soso</creatorcontrib><creatorcontrib>Laubner, Gabija</creatorcontrib><creatorcontrib>Liakoni, Evangelia</creatorcontrib><creatorcontrib>Liechti, Matthias E.</creatorcontrib><creatorcontrib>Lyphout, Cathelijne</creatorcontrib><creatorcontrib>Mégarbane, Bruno</creatorcontrib><creatorcontrib>Miró, Òscar</creatorcontrib><creatorcontrib>Moughty, Adrian</creatorcontrib><creatorcontrib>Müller, Laura</creatorcontrib><creatorcontrib>O'Connor, Niall</creatorcontrib><creatorcontrib>Paasma, Raido</creatorcontrib><creatorcontrib>Perez, Juan Ortega</creatorcontrib><creatorcontrib>Perminas, Marius</creatorcontrib><creatorcontrib>Persett, Per Sverre</creatorcontrib><creatorcontrib>Põld, Kristiina</creatorcontrib><creatorcontrib>Puiguriguer, Jordi</creatorcontrib><creatorcontrib>Radenkova-Saeva, Julia</creatorcontrib><creatorcontrib>Rulisek, Jan</creatorcontrib><creatorcontrib>Schmid, Yasmin</creatorcontrib><creatorcontrib>Scholz, Irene</creatorcontrib><creatorcontrib>Sopirala, Radhika</creatorcontrib><creatorcontrib>Surkus, Jonas</creatorcontrib><creatorcontrib>Toth, Ibolya</creatorcontrib><creatorcontrib>Vallersnes, Odd Martin</creatorcontrib><creatorcontrib>Vigorita, Federico</creatorcontrib><creatorcontrib>Waldman, Wojciech</creatorcontrib><creatorcontrib>Waring, W. Stephen</creatorcontrib><creatorcontrib>Zacharov, Sergej</creatorcontrib><creatorcontrib>Euro-DEN Research Group</creatorcontrib><title>Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set</title><title>Neurotoxicology (Park Forest South)</title><addtitle>Neurotoxicology</addtitle><description>•Seizures occurred in 4% of recreational drug presentations to emergency departments.•Fentanyl, synthetic cannabinoids, and MDMA associated with increased seizures.•Seizures after recreational drug use associated with worse clinical outcomes. Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20–5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19–3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35–0.61), clonazepam (OR 0.22, 95% CI 0.06–0.91), and cannabis (OR 0.65, 95% CI 0.50–0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.</description><subject>Acute toxicity</subject><subject>Adult</subject><subject>Body Temperature - drug effects</subject><subject>Cannabinoids</subject><subject>Cannabinoids - adverse effects</subject><subject>Cannabinoids - chemical synthesis</subject><subject>Cannabis</subject><subject>Cardiology and cardiovascular system</subject><subject>Clonazepam</subject><subject>Coma</subject><subject>Complications</subject><subject>Confidence intervals</subject><subject>Datasets</subject><subject>Demographics</subject><subject>Drug abuse</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Emerging diseases</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Hemodynamics - drug effects</subject><subject>Heroin</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Illicit Drugs - adverse effects</subject><subject>Illicit Drugs - chemical synthesis</subject><subject>Incidence</subject><subject>Infectious diseases</subject><subject>Intoxication</subject><subject>Intubation</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Narcotic Antagonists - adverse effects</subject><subject>New psychoactive substances</subject><subject>Opioid-Related Disorders - epidemiology</subject><subject>Prognosis</subject><subject>Psychotropic Drugs - adverse effects</subject><subject>Psychotropic Drugs - chemical synthesis</subject><subject>Pulmonology and respiratory tract</subject><subject>Recreational drug</subject><subject>Recreational use</subject><subject>Respiration - drug effects</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Seizure</subject><subject>Seizures</subject><subject>Seizures - chemically induced</subject><subject>Seizures - diagnosis</subject><subject>Seizures - epidemiology</subject><subject>Seizures - physiopathology</subject><subject>Substance-Related Disorders - diagnosis</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>Substance-Related Disorders - physiopathology</subject><subject>Synthetic cannabinoid</subject><subject>Toxicity</subject><subject>Toxicology</subject><issn>0161-813X</issn><issn>1872-9711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVtrFDEUgIModm39BYIEfKkPM-YkM7kIPiztaoVFCyoIPoRs5qzNMrtZk5lC--ub6dY--CAEDid855J8hLwCVgMD-W5T73BMseYMTM2amjHxhMxAK14ZBfCUzAoFlQbx84i8yHnDGLRKmufkSDCjGhB8Rn59w3A7JszUlUN93O774N0Q4o7GNU3oE95nrqddGn_TMeN7Oi_pTQ55QoYrpIuyR3W--EIv-zHTzg2uyjickGdr12d8-RCPyY-Pi-9nF9Xy66fPZ_Nl5ZtGDVUrV0IiMOldZ7wyHkEKvcIWGuaAKS45d6KTonVcGZAatSpRt2IFEr0Sx-Ttoe-V6-0-ha1LNza6YC_mSzvdMaFbY0xzDYU9PbD7FP-MmAe7Ddlj37sdxjFbzpmRjCuY2r75B93EMZWXT5TUUvOm0YUSB8qnmHPC9eMGwOzkyW7svSc7ebKsscVTqXr90HtcbbF7rPkrpgAfDgCWj7sOmGz2AXceu1CcDLaL4b8D7gCwkaGM</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Wolfe, Caitlin E.</creator><creator>Wood, David M.</creator><creator>Dines, Alison</creator><creator>Whatley, Benjamin P.</creator><creator>Yates, Christopher</creator><creator>Heyerdahl, Fridtjof</creator><creator>Hovda, Knut Erik</creator><creator>Giraudon, Isabelle</creator><creator>Dargan, Paul I.</creator><creator>Anseeuw, Kurt</creator><creator>Badaras, Robertas</creator><creator>Bonnici, Jeffrey</creator><creator>Brvar, Miran</creator><creator>Caganova, Blazena</creator><creator>Ceschi, Alessandro</creator><creator>Eyer, Florian</creator><creator>Galicia, Miguel</creator><creator>Geith, Stefanie</creator><creator>Gillebeert, Johan</creator><creator>Grenc, Damjan</creator><creator>Gorozia, Ketevan</creator><creator>Jaffal, Karim</creator><creator>Jürgens, Gesche</creator><creator>Kabata, Piotr Maciej</creator><creator>Kennedy, Iarlaith</creator><creator>Konstari, Jutta</creator><creator>Kutubidze, Soso</creator><creator>Laubner, Gabija</creator><creator>Liakoni, Evangelia</creator><creator>Liechti, Matthias E.</creator><creator>Lyphout, Cathelijne</creator><creator>Mégarbane, Bruno</creator><creator>Miró, Òscar</creator><creator>Moughty, Adrian</creator><creator>Müller, Laura</creator><creator>O'Connor, Niall</creator><creator>Paasma, Raido</creator><creator>Perez, Juan Ortega</creator><creator>Perminas, Marius</creator><creator>Persett, Per Sverre</creator><creator>Põld, Kristiina</creator><creator>Puiguriguer, Jordi</creator><creator>Radenkova-Saeva, Julia</creator><creator>Rulisek, Jan</creator><creator>Schmid, Yasmin</creator><creator>Scholz, Irene</creator><creator>Sopirala, Radhika</creator><creator>Surkus, Jonas</creator><creator>Toth, Ibolya</creator><creator>Vallersnes, Odd Martin</creator><creator>Vigorita, Federico</creator><creator>Waldman, Wojciech</creator><creator>Waring, W. Stephen</creator><creator>Zacharov, Sergej</creator><general>Elsevier B.V</general><general>Elsevier BV</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2522-2764</orcidid></search><sort><creationdate>20190701</creationdate><title>Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set</title><author>Wolfe, Caitlin E. ; Wood, David M. ; Dines, Alison ; Whatley, Benjamin P. ; Yates, Christopher ; Heyerdahl, Fridtjof ; Hovda, Knut Erik ; Giraudon, Isabelle ; Dargan, Paul I. ; Anseeuw, Kurt ; Badaras, Robertas ; Bonnici, Jeffrey ; Brvar, Miran ; Caganova, Blazena ; Ceschi, Alessandro ; Eyer, Florian ; Galicia, Miguel ; Geith, Stefanie ; Gillebeert, Johan ; Grenc, Damjan ; Gorozia, Ketevan ; Jaffal, Karim ; Jürgens, Gesche ; Kabata, Piotr Maciej ; Kennedy, Iarlaith ; Konstari, Jutta ; Kutubidze, Soso ; Laubner, Gabija ; Liakoni, Evangelia ; Liechti, Matthias E. ; Lyphout, Cathelijne ; Mégarbane, Bruno ; Miró, Òscar ; Moughty, Adrian ; Müller, Laura ; O'Connor, Niall ; Paasma, Raido ; Perez, Juan Ortega ; Perminas, Marius ; Persett, Per Sverre ; Põld, Kristiina ; Puiguriguer, Jordi ; Radenkova-Saeva, Julia ; Rulisek, Jan ; Schmid, Yasmin ; Scholz, Irene ; Sopirala, Radhika ; Surkus, Jonas ; Toth, Ibolya ; Vallersnes, Odd Martin ; Vigorita, Federico ; Waldman, Wojciech ; Waring, W. Stephen ; Zacharov, Sergej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-56b36e106cad9c79ce1638be5140a1072622a3d635a279168e87791853b16ec73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute toxicity</topic><topic>Adult</topic><topic>Body Temperature - drug effects</topic><topic>Cannabinoids</topic><topic>Cannabinoids - adverse effects</topic><topic>Cannabinoids - chemical synthesis</topic><topic>Cannabis</topic><topic>Cardiology and cardiovascular system</topic><topic>Clonazepam</topic><topic>Coma</topic><topic>Complications</topic><topic>Confidence intervals</topic><topic>Datasets</topic><topic>Demographics</topic><topic>Drug abuse</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Emerging diseases</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Hemodynamics - drug effects</topic><topic>Heroin</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Illicit Drugs - adverse effects</topic><topic>Illicit Drugs - chemical synthesis</topic><topic>Incidence</topic><topic>Infectious diseases</topic><topic>Intoxication</topic><topic>Intubation</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Narcotic Antagonists - adverse effects</topic><topic>New psychoactive substances</topic><topic>Opioid-Related Disorders - epidemiology</topic><topic>Prognosis</topic><topic>Psychotropic Drugs - adverse effects</topic><topic>Psychotropic Drugs - chemical synthesis</topic><topic>Pulmonology and respiratory tract</topic><topic>Recreational drug</topic><topic>Recreational use</topic><topic>Respiration - drug effects</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Seizure</topic><topic>Seizures</topic><topic>Seizures - chemically induced</topic><topic>Seizures - diagnosis</topic><topic>Seizures - epidemiology</topic><topic>Seizures - physiopathology</topic><topic>Substance-Related Disorders - diagnosis</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>Substance-Related Disorders - physiopathology</topic><topic>Synthetic cannabinoid</topic><topic>Toxicity</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolfe, Caitlin E.</creatorcontrib><creatorcontrib>Wood, David M.</creatorcontrib><creatorcontrib>Dines, Alison</creatorcontrib><creatorcontrib>Whatley, Benjamin P.</creatorcontrib><creatorcontrib>Yates, Christopher</creatorcontrib><creatorcontrib>Heyerdahl, Fridtjof</creatorcontrib><creatorcontrib>Hovda, Knut Erik</creatorcontrib><creatorcontrib>Giraudon, Isabelle</creatorcontrib><creatorcontrib>Dargan, Paul I.</creatorcontrib><creatorcontrib>Anseeuw, Kurt</creatorcontrib><creatorcontrib>Badaras, Robertas</creatorcontrib><creatorcontrib>Bonnici, Jeffrey</creatorcontrib><creatorcontrib>Brvar, Miran</creatorcontrib><creatorcontrib>Caganova, Blazena</creatorcontrib><creatorcontrib>Ceschi, Alessandro</creatorcontrib><creatorcontrib>Eyer, Florian</creatorcontrib><creatorcontrib>Galicia, Miguel</creatorcontrib><creatorcontrib>Geith, Stefanie</creatorcontrib><creatorcontrib>Gillebeert, Johan</creatorcontrib><creatorcontrib>Grenc, Damjan</creatorcontrib><creatorcontrib>Gorozia, Ketevan</creatorcontrib><creatorcontrib>Jaffal, Karim</creatorcontrib><creatorcontrib>Jürgens, Gesche</creatorcontrib><creatorcontrib>Kabata, Piotr Maciej</creatorcontrib><creatorcontrib>Kennedy, Iarlaith</creatorcontrib><creatorcontrib>Konstari, Jutta</creatorcontrib><creatorcontrib>Kutubidze, Soso</creatorcontrib><creatorcontrib>Laubner, Gabija</creatorcontrib><creatorcontrib>Liakoni, Evangelia</creatorcontrib><creatorcontrib>Liechti, Matthias E.</creatorcontrib><creatorcontrib>Lyphout, Cathelijne</creatorcontrib><creatorcontrib>Mégarbane, Bruno</creatorcontrib><creatorcontrib>Miró, Òscar</creatorcontrib><creatorcontrib>Moughty, Adrian</creatorcontrib><creatorcontrib>Müller, Laura</creatorcontrib><creatorcontrib>O'Connor, Niall</creatorcontrib><creatorcontrib>Paasma, Raido</creatorcontrib><creatorcontrib>Perez, Juan Ortega</creatorcontrib><creatorcontrib>Perminas, Marius</creatorcontrib><creatorcontrib>Persett, Per Sverre</creatorcontrib><creatorcontrib>Põld, Kristiina</creatorcontrib><creatorcontrib>Puiguriguer, Jordi</creatorcontrib><creatorcontrib>Radenkova-Saeva, Julia</creatorcontrib><creatorcontrib>Rulisek, Jan</creatorcontrib><creatorcontrib>Schmid, Yasmin</creatorcontrib><creatorcontrib>Scholz, Irene</creatorcontrib><creatorcontrib>Sopirala, Radhika</creatorcontrib><creatorcontrib>Surkus, Jonas</creatorcontrib><creatorcontrib>Toth, Ibolya</creatorcontrib><creatorcontrib>Vallersnes, Odd Martin</creatorcontrib><creatorcontrib>Vigorita, Federico</creatorcontrib><creatorcontrib>Waldman, Wojciech</creatorcontrib><creatorcontrib>Waring, W. Stephen</creatorcontrib><creatorcontrib>Zacharov, Sergej</creatorcontrib><creatorcontrib>Euro-DEN Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Neurotoxicology (Park Forest South)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolfe, Caitlin E.</au><au>Wood, David M.</au><au>Dines, Alison</au><au>Whatley, Benjamin P.</au><au>Yates, Christopher</au><au>Heyerdahl, Fridtjof</au><au>Hovda, Knut Erik</au><au>Giraudon, Isabelle</au><au>Dargan, Paul I.</au><au>Anseeuw, Kurt</au><au>Badaras, Robertas</au><au>Bonnici, Jeffrey</au><au>Brvar, Miran</au><au>Caganova, Blazena</au><au>Ceschi, Alessandro</au><au>Eyer, Florian</au><au>Galicia, Miguel</au><au>Geith, Stefanie</au><au>Gillebeert, Johan</au><au>Grenc, Damjan</au><au>Gorozia, Ketevan</au><au>Jaffal, Karim</au><au>Jürgens, Gesche</au><au>Kabata, Piotr Maciej</au><au>Kennedy, Iarlaith</au><au>Konstari, Jutta</au><au>Kutubidze, Soso</au><au>Laubner, Gabija</au><au>Liakoni, Evangelia</au><au>Liechti, Matthias E.</au><au>Lyphout, Cathelijne</au><au>Mégarbane, Bruno</au><au>Miró, Òscar</au><au>Moughty, Adrian</au><au>Müller, Laura</au><au>O'Connor, Niall</au><au>Paasma, Raido</au><au>Perez, Juan Ortega</au><au>Perminas, Marius</au><au>Persett, Per Sverre</au><au>Põld, Kristiina</au><au>Puiguriguer, Jordi</au><au>Radenkova-Saeva, Julia</au><au>Rulisek, Jan</au><au>Schmid, Yasmin</au><au>Scholz, Irene</au><au>Sopirala, Radhika</au><au>Surkus, Jonas</au><au>Toth, Ibolya</au><au>Vallersnes, Odd Martin</au><au>Vigorita, Federico</au><au>Waldman, Wojciech</au><au>Waring, W. Stephen</au><au>Zacharov, Sergej</au><aucorp>Euro-DEN Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set</atitle><jtitle>Neurotoxicology (Park Forest South)</jtitle><addtitle>Neurotoxicology</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>73</volume><spage>183</spage><epage>187</epage><pages>183-187</pages><issn>0161-813X</issn><eissn>1872-9711</eissn><abstract>•Seizures occurred in 4% of recreational drug presentations to emergency departments.•Fentanyl, synthetic cannabinoids, and MDMA associated with increased seizures.•Seizures after recreational drug use associated with worse clinical outcomes. Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20–5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19–3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35–0.61), clonazepam (OR 0.22, 95% CI 0.06–0.91), and cannabis (OR 0.65, 95% CI 0.50–0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30974132</pmid><doi>10.1016/j.neuro.2019.04.003</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-2522-2764</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0161-813X
ispartof Neurotoxicology (Park Forest South), 2019-07, Vol.73, p.183-187
issn 0161-813X
1872-9711
language eng
recordid cdi_hal_primary_oai_HAL_hal_03859994v1
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute toxicity
Adult
Body Temperature - drug effects
Cannabinoids
Cannabinoids - adverse effects
Cannabinoids - chemical synthesis
Cannabis
Cardiology and cardiovascular system
Clonazepam
Coma
Complications
Confidence intervals
Datasets
Demographics
Drug abuse
Drug use
Drugs
Emerging diseases
Europe - epidemiology
Female
Fentanyl
Hemodynamics - drug effects
Heroin
Human health and pathology
Humans
Illicit Drugs - adverse effects
Illicit Drugs - chemical synthesis
Incidence
Infectious diseases
Intoxication
Intubation
Life Sciences
Male
Narcotic Antagonists - adverse effects
New psychoactive substances
Opioid-Related Disorders - epidemiology
Prognosis
Psychotropic Drugs - adverse effects
Psychotropic Drugs - chemical synthesis
Pulmonology and respiratory tract
Recreational drug
Recreational use
Respiration - drug effects
Risk Assessment
Risk Factors
Seizure
Seizures
Seizures - chemically induced
Seizures - diagnosis
Seizures - epidemiology
Seizures - physiopathology
Substance-Related Disorders - diagnosis
Substance-Related Disorders - epidemiology
Substance-Related Disorders - physiopathology
Synthetic cannabinoid
Toxicity
Toxicology
title Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seizures%20as%20a%20complication%20of%20recreational%20drug%20use:%20Analysis%20of%20the%20Euro-DEN%20Plus%20data-set&rft.jtitle=Neurotoxicology%20(Park%20Forest%20South)&rft.au=Wolfe,%20Caitlin%20E.&rft.aucorp=Euro-DEN%20Research%20Group&rft.date=2019-07-01&rft.volume=73&rft.spage=183&rft.epage=187&rft.pages=183-187&rft.issn=0161-813X&rft.eissn=1872-9711&rft_id=info:doi/10.1016/j.neuro.2019.04.003&rft_dat=%3Cproquest_hal_p%3E2209602717%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2268682448&rft_id=info:pmid/30974132&rft_els_id=S0161813X19300324&rfr_iscdi=true